本页面由Tiger Trade Technology Pte. Ltd.提供服务

MEDLAB CLINICAL LTD

6.600
0.000
成交量:- -
成交额:- -
市值:1,507.11万
市盈率:-7.07
高:6.600
开:6.600
低:6.600
收:6.600
52周最高:6.600
52周最低:6.600
股本:228.35万
流通股本:155.07万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.933
每股收益(LYR):-0.933
净资产收益率:-993.06%
总资产收益率:-85.31%
市净率:-17.71
市盈率(LYR):-7.07

数据加载中...

公司资料

公司名字:
MEDLAB CLINICAL LTD
交易所:
ASX
成立时间:
- -
员工人数:
- -
公司地址:
- -
邮编:
- -
电话:
- -
传真:
- -
简介:
Medlab Clinical Limited engages in the sale of nutraceutical products, and pharmaceutical research and commercialization in Australia. The company develops bio-therapeutics for bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, and musculoskeletal muscle loss associated with ageing. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. Medlab Clinical Limited was founded in 2012 and is based in Alexandria, Australia.